Skip to main content
Clinical Trials/CTRI/2022/10/046368
CTRI/2022/10/046368
Completed
Phase 2

â??A Clinical study to evaluate the safety and efficacy of Chawayanshakti Powder as physical health and immunity boosterâ??.

KAG Industries, Nahan H.P0 sites35 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
KAG Industries, Nahan H.P
Enrollment
35
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 9, 2023
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
KAG Industries, Nahan H.P

Eligibility Criteria

Inclusion Criteria

  • healthy individuals in the age group of 18\-65 years willing for trial and able to come for follow up.

Exclusion Criteria

  • individuals who are unwilling for trial or below 18 and above 65 years of age or having any concomitant illness requiring medical intervention. individuals allergic to milk or components of Chawayan shakti powder.

Outcomes

Primary Outcomes

Not specified

Similar Trials